DIA Offers Clinical Safety and Pharmacovigilance Certification

Wednesday, December 30, 2009 07:21 AM

The Drug Information Association (DIA) recently launched its Clinical Safety and Pharmacovigilance Certificate Program—the organization’s third certificate program for clinical research professionals.

The new program focuses on topics related to pre- and postmarketing clinical safety and pharmacovigilance, risk-management strategies, safety inspections, signal detection and data mining, medical approaches in diagnosis and management of adverse drug reactions and drug safety surveillance and epidemiology.

Enrollment in the program is free, and fees for each course vary based on length.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs